microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. 2009

Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
Departments of Pathology and Pharmacology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.

microRNAs (miRNA) are small noncoding RNAs that participate in diverse biological processes by suppressing target gene expression. Altered expression of miR-21 has been reported in cancer. To gain insights into its potential role in tumorigenesis, we generated miR-21 knockout colon cancer cells through gene targeting. Unbiased microarray analysis combined with bioinformatics identified cell cycle regulator Cdc25A as a miR-21 target. miR-21 suppressed Cdc25A expression through a defined sequence in its 3'-untranslated region. We found that miR-21 is induced by serum starvation and DNA damage, negatively regulates G(1)-S transition, and participates in DNA damage-induced G(2)-M checkpoint through down-regulation of Cdc25A. In contrast, miR-21 deficiency did not affect apoptosis induced by a variety of commonly used anticancer agents or cell proliferation under normal cell culture conditions. Furthermore, miR-21 was found to be underexpressed in a subset of Cdc25A-overexpressing colon cancers. Our data show a role of miR-21 in modulating cell cycle progression following stress, providing a novel mechanism of Cdc25A regulation and a potential explanation of miR-21 in tumorigenesis.

UI MeSH Term Description Entries
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D008940 Mitotic Index An expression of the number of mitoses found in a stated number of cells. Index, Mitotic,Indices, Mitotic,Mitotic Indices
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
October 2010, Anti-cancer drugs,
Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
March 2011, Anti-cancer drugs,
Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
June 2008, Carcinogenesis,
Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
April 2019, Journal of cellular physiology,
Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
January 2022, Cancer cell international,
Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
January 2022, Journal of oncology,
Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
May 2019, Journal of cellular biochemistry,
Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
January 2013, Stem cell research & therapy,
Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
March 2009, Biochemical and biophysical research communications,
Peng Wang, and Fangdong Zou, and Xiaodong Zhang, and Hua Li, and Austin Dulak, and Robert J Tomko, and John S Lazo, and Zhenghe Wang, and Lin Zhang, and Jian Yu
January 2019, Cellular & molecular biology letters,
Copied contents to your clipboard!